A third of pharma executives want to trial smartphone medication reminders, says KPMG
Smartphone apps could be used to help patients stick to medication schedules, according to a report released today (July 8) from auditors KPMG. The report, titled More than Medicine, acknowledges that drug effectiveness diminishes over time as patients stop taking prescribed therapies of their own volition and said this cost an estimated $290 billion in the USA in 2009.
It suggests that compliance could be improved through smartphone apps designed to help patients stick to medication schedules and cites wider evidence arguing that one in three pharmaceutical executives are already planning to go down this route.
The findings were part of a report which said the life sciences industry will have to “align its interests” with the UK’s National Health Service (NHS) as an aging population, unhealthy lifestyles and long-term conditions take their toll on the UK’s health care services.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Generics
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze